EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

New Advances and Current Trends in Bioavailability of Coffee and Coffee By-Product Constituents and Their Metabolites: A Review

Boris Nemzer iD, Fadwa Al-Taher, Nebiyu Abshiru, Elvira de Mejia iD

International Journal of Molecular Sciences · 03.11.2026 · 27 (21) · 9841

DOI: 10.3390/ijms27219841 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 03.11.2026. Verfasst von Boris Nemzer und 3 weiteren Autor:innen. Beteiligte Einrichtung: VDF FutureCeuticals, Inc., Momence, IL 60954, USA. Hauptthemen laut MEDLINE: Coffee. Die Arbeit nennt 154 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Coffee is one of the most widely consumed beverages worldwide, yet understanding how its bioactive compounds are absorbed and exert health effects remains incomplete. The objective and scope of this review is to critically summarize current advances in coffee bioavailability research, identify major limitations, and highlight emerging research trends. Recent research has advanced in three core areas. First, genetic stratification has moved the field beyond one-size-fits-all approaches by genotyping for key polymorphisms to explain inter-individual variability. Second, advanced metabolomics, including targeted and untargeted LC-MS/MS and multi-omics integration, has provided comprehensive views of phenolic absorption and bioavailability. Third, rigorous intervention designs, including randomized crossover trials and large prospective cohorts with detailed exposure assessment, have improved causal inference. Despite these advances, major limitations persist. Many studies lack sufficient statistical power to detect gene-treatment interactions. The clinical relevance of discovered metabolites is often not established. Observational cohorts remain susceptible to residual confounding, and the field lacks a standardized food matrix for cross-study comparisons. Key strategies to improve the bioavailability of coffee and its by-products were proposed, including novel delivery systems for coffee phytochemicals, human clinical trials involving encapsulated coffee bioactive compounds, and exploring coffee by-products as novel bioactive sources.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CoffeeHumansBiological AvailabilityAnimalsMetabolomicsPhytochemicalsCaffeine

Stichwörter der Autor:innen

bioactivesbioavailabilitycaffeinechlorogenic acidscoffeedelivery systems

Substanzen

CoffeePhytochemicalsCaffeine

Autor:innen und Institutionen

  • VDF FutureCeuticals, Inc., Momence, IL 60954, USA.
  • 228 ER Madigan Laboratory, Department of Food Science and Human Nutrition, University of Illinois, Urbana-Champaign, 1201 W. Gregory Dr., Urbana, IL 61801, USA.

ORCID-Profile: Boris Nemzer, Elvira de Mejia

Zitieren

APA

Nemzer, B., Al-Taher, F., Abshiru, N., & de Mejia, E. (2026). New Advances and Current Trends in Bioavailability of Coffee and Coffee By-Product Constituents and Their Metabolites: A Review. International Journal of Molecular Sciences, 27(21), 9841. https://doi.org/10.3390/ijms27219841

Vancouver

Nemzer B, Al-Taher F, Abshiru N, de Mejia E. New Advances and Current Trends in Bioavailability of Coffee and Coffee By-Product Constituents and Their Metabolites: A Review. International Journal of Molecular Sciences. 2026;27(21):9841. doi:10.3390/ijms27219841

BibTeX
@article{Nemzer2026,
  author = {Nemzer, Boris and Al-Taher, Fadwa and Abshiru, Nebiyu and de Mejia, Elvira},
  title = {New Advances and Current Trends in Bioavailability of Coffee and Coffee By-Product Constituents and Their Metabolites: A Review},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {21},
  pages = {9841},
  doi = {10.3390/ijms27219841}
}
Kostenlos starten →